marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-08-2024
Y-mAbs Therapeutics Financial Statements 2011-2024 | YMAB
Annual Financial Statements Y-mAbs Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
724 M | 134 M | 393 M | 1.69 B | 1.19 B | 583 M | - | - | - | - | - | - | - |
Shares |
43.6 M | 43.7 M | 43.2 M | 40.2 M | 35.2 M | 28.8 M | - | - | - | - | - | - | - |
Historical Prices |
16.6 | 3.06 | 9.11 | 35.2 | 29.4 | 21.6 | - | - | - | - | - | - | - |
Net Income |
-21.4 M | -95.6 M | -55.3 M | -119 M | -81 M | -43.3 M | -19.2 M | -17.1 M | - | - | - | - | - |
Revenue |
84.8 M | 65.3 M | 34.9 M | 20.8 M | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
11.4 M | 7.47 M | 2.3 M | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 18.5 M | - | - | - | - | - | - | - | - | - |
Operating Income |
-25.7 M | -94.8 M | -115 M | -120 M | -83 M | -43.2 M | -19.2 M | - | - | - | - | - | - |
Interest Expense |
- | - | -1.85 M | 598 K | 1.98 M | -44 K | 83 K | - | - | - | - | - | - |
EBITDA |
-24.9 M | -94 M | -115 M | -120 M | -82.8 M | -43.2 M | -19.2 M | -17 M | - | - | - | - | - |
Operating Expenses |
- | - | - | 138 M | 83 M | 43.2 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
44.9 M | 60.9 M | 54.6 M | 44.8 M | 19.5 M | 8.96 M | 4.94 M | 3.18 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Y-mAbs Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
44.6 M | 44 M | 43.8 M | 43.7 M | 43.6 M | 43.7 M | 43.7 M | - | 43.7 M | 43.7 M | 43.7 M | 43.7 M | 43.6 M | 43.6 M | 41.9 M | - | 40.2 M | 40 M | 39.8 M | - | 34.4 M | 34.2 M | 34.2 M | 34.2 M | 27.3 M | 26.7 M | 26.7 M | - | 17.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-7 M | -9.25 M | -6.63 M | - | -7.75 M | -6.3 M | -6.39 M | - | -27.5 M | -41.1 M | -28.1 M | - | -28.9 M | -22.9 M | 33.4 M | -19.9 M | -32.8 M | -40.4 M | -26.2 M | -23.1 M | -23.9 M | -18 M | -15.9 M | -14.1 M | -11.4 M | -10.3 M | -7.48 M | -9.25 M | -3.83 M | -3.19 M | -2.89 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
18.5 M | 22.8 M | 19.9 M | - | 20.5 M | 20.8 M | 20.3 M | - | 12.5 M | 10.8 M | 10.5 M | - | 8.96 M | 11 M | 5.38 M | 20.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
2.25 M | 3.01 M | 2.1 M | - | 2.6 M | 4.65 M | 2.08 M | - | 2.48 M | 1.14 M | 1.83 M | - | 550 K | 200 K | 93 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-8.57 M | -9.79 M | -6.91 M | - | -7.75 M | -7.22 M | -7.5 M | - | -26 M | -39.9 M | -27.7 M | - | -28.7 M | -22.7 M | -28.3 M | -20.1 M | -32.6 M | -40.5 M | -26.7 M | -23.8 M | -24.4 M | -18.6 M | -16.3 M | -14.1 M | -11.4 M | -10.3 M | -7.48 M | -9.28 M | -3.84 M | -3.23 M | -2.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | 1.11 M | - | -1.51 M | -1.19 M | -373 K | - | -154 K | -225 K | -338 K | - | -191 K | 59 K | 568 K | - | 437 K | 598 K | 319 K | - | -11 K | -47 K | -4 K | - | 15 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -6.75 M | - | - | - | -7.32 M | - | -25.4 M | -39.9 M | -27.5 M | - | -28.2 M | -22.7 M | -28.1 M | -20.1 M | -32.4 M | -40.3 M | -26.7 M | -23.8 M | -24.3 M | -18.6 M | -16.2 M | -14.1 M | -11.4 M | -10.3 M | -7.48 M | -9.28 M | -3.84 M | -3.23 M | -2.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 32.6 M | 40.5 M | 26.7 M | - | 24.4 M | 18.6 M | 16.3 M | - | 11.4 M | 10.3 M | 7.48 M | - | 3.84 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
13.6 M | 17.2 M | 11.4 M | - | 10.2 M | 11.3 M | 12.3 M | - | 13.6 M | 23.1 M | 13.4 M | - | 14 M | 13.5 M | 12 M | - | 11.6 M | 10.4 M | 8.12 M | - | 4.7 M | 4.14 M | 3.74 M | - | 2.68 M | 1.96 M | 1.28 M | - | 766 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency